PROSPECTIVE CLINICAL STUDY OF BI-IMPLANT SYSTEM SUCCESS RATE:THREE-YEAR FOLLOW-UP AFTER THE IMPLANTATION
Abstract
BACKGROUND This article provides preliminary clinical results on the Bi-implant system, which was developed to simplify surgical procedure.Materials and Total of 114 implants (52 maxillary and 62 mandibular) were placed in 85 patients. Themethods implants were placed in healed sites. Before II. stage procedure healing times of 3 monthsfor the mandible and 4 months for the maxilla were allowed. Cumulative survival rateswere calculated for up to 36 months of follow-up after surgery. RESULTS 2 implants failed during the healing period, none failed after prosthetic rehabilitation. CONCLUSIONS These preliminary data suggest that the Bi-Implant system can be predictableDownloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
